Skip to main content
. Author manuscript; available in PMC: 2016 Feb 10.
Published in final edited form as: Anticancer Drugs. 2016 Mar;27(3):216–224. doi: 10.1097/CAD.0000000000000319

Figure 3. VRL on apoptosis and cell cycle.

Figure 3

HUVEC were treated with VRL for 96h (0.001, 0.1 and 1nM; metronomic model) or for 4h with a wash-out period of 92h (10 to 1000nM; conventional chemotherapy). Percentages of viable, total apoptotic and necrotic cells (A) or cells in cell cycle phases (B) in metronomic (left) vs. conventional (right) chemotherapy were recorded. *p<0.05 compared with control group.